NDC 15631-0141

CISTUS CANADENSIS

Cistus Canadensis

CISTUS CANADENSIS is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Helianthemum Canadense.

Product ID15631-0141_a1084922-ec92-dabc-e053-2a95a90a0451
NDC15631-0141
Product TypeHuman Otc Drug
Proprietary NameCISTUS CANADENSIS
Generic NameCistus Canadensis
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-10-02
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameHELIANTHEMUM CANADENSE
Active Ingredient Strength1 [hp_X]/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 15631-0141-0

100 PELLET in 1 PACKAGE (15631-0141-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0141-1 [15631014101]

CISTUS CANADENSIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-17

NDC 15631-0141-0 [15631014100]

CISTUS CANADENSIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-17

NDC 15631-0141-5 [15631014105]

CISTUS CANADENSIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-17

NDC 15631-0141-4 [15631014104]

CISTUS CANADENSIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-17

NDC 15631-0141-3 [15631014103]

CISTUS CANADENSIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-17

NDC 15631-0141-2 [15631014102]

CISTUS CANADENSIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-17

Drug Details

Active Ingredients

IngredientStrength
HELIANTHEMUM CANADENSE1 [hp_X]/1

OpenFDA Data

SPL SET ID:ce51c671-e05b-4653-9c71-55ca0cc9cfef
Manufacturer
UNII

NDC Crossover Matching brand name "CISTUS CANADENSIS" or generic name "Cistus Canadensis"

NDCBrand NameGeneric Name
15631-0141CISTUS CANADENSISCISTUS CANADENSIS
68428-323Cistus canadensisHELIANTHEMUM CANADENSE
71919-205Cistus canadensisHELIANTHEMUM CANADENSE

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.